New cell therapy offers hope for advanced ALS patients
Disease control
TEMPORARILY_NOT_AVAILABLE
This trial provides access to an experimental cell therapy called RAPA-501 for people with advanced ALS who cannot join other studies. Doctors collect a patient's own immune cells, reprogram them in a lab to reduce inflammation, and infuse them back into the patient up to four ti…
Sponsor: Rapa Therapeutics LLC • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC